RARA CRAFT DATABASE for FDA Medical Devices
510(k)K222998

FDA DEVICE FACTS

F3

Acrew Imaging, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 20, 2023PRODUCT CODEOWB

Indications for use

F3 provides image guidance by overlaying a previously constructed preoperative vessel anatomy, from a previously acquired contrast-enhanced, diagnostic CT scan, onto live fluoroscopic images in order to assist in the positioning of guidewires, catheters and other endovascular devices.

F3 is intended to assist fluoroscopy-guided endovascular procedures in the thorax. Suitable procedures include endovascular aortic aneurysm repair (AAA and mid-distal TAA) and angioplasty.

F3 is not intended for use in the X-ray guided procedures in the liver, kidneys or pelvic organs.

Predicate Product Comparison Comments Acrew Cydar Comments 510(k) Number K160088 Product Code OWB OWB Same Regulation Number §892.1650 §892.1650 Same Regulation Name Image-Intensified Fluoroscopic X-Ray Image-Intensified Fluoroscopic X-Ray Same Comments Acrew Cydar Comments System System Intended Use Display of combined live 2D Xray fluoroscopy and 3D anatomy for image guidance during surgery procedures in the lower thorax. Display of combined live 2D Xray fluoroscopy and 3D anatomy for image guidance during surgery procedures in the lower thorax, abdomen and pelvis.. Our product has not been evaluated for the use in abdomen and pelvis, so our intended use in the lower thorax is a subset of the predicate. 3-D Imaging Pre-operative Pre-operative Same X-Ray Fluoroscopy Live Live Same Construction Software Product Software Product Same Host Computer Container suitable for running on a local computer or the cloud. Separate interventional tools workstation Our software runs in a container allowing it to be used on a local computer or in the cloud. Registration Overview 2D-3D registration is achieved by machine vision tracking of vertebral anatomy combined with iterative intensity based similarity. 2D-3D registration is achieved by machine vision tracking of vertebral anatomy To increase the robustness of the registration F# utilize both computer vision and an intensity based registration engine to find a 2D- 3D registration result. Registration Target Anatomy present Vertebral anatomy Mutual information will use vertebral anatomy to guide registration, but will also utilize other structures present in both the CT and the fluoroscopic image to enhance Comments Acrew Cydar Comments the accuracy and robustness of the registration. Patient Contacting No No Same Energy emitted or absorbed No No Same Dynamic update on C-arm / table motion Automatic Automatic Same Dynamic update on patient motion Automatic Automatic Same Anatomical Location Vascular anatomy of the chest, abdomen and pelvis. Vascular anatomy of the chest, abdomen and pelvis. Same Ability to store roadmaps No Yes F3 is a visualization aid, not intended to support planning such as roadmaps. Ability to store snapshots Yes Yes Same Non-clinical Performance Data IEC 62304 Applied Applied Same IEC 62366 Applied Applied Same ISO 14971 Applied Applied Same NEMA PS 3.1-3.20 DICOM

Discussion of Technological Differences Indications for Use statement - The salient use difference between F3 and Cydar EV is F3 lacks a tool for constructing 3D vessel anatomy. Instead, users must create their own contours using other tools and then export them to F3. Once transferred to F3, the use of the tools is similar providing the overlay of the provided structures using the original CT used to create the structure. The lack of tool for constructing 3D vessel anatomy raises no new issue of safety and effectiveness. Host computer – F3 software runs in a container allowing it to be used on a local computer or in the cloud, whereas the Cydar EV uses separate interventional tools workstation. The differences in host computers raises no new issue of safety and effectiveness.

Registration Overview - To increase the robustness of the registration, F3 utilizes both computer vision and an intensity based registration engine to find a 2D-3D registration result. The Cydar EV 2D-3D registration is achieved by machine vision tracking of vertebral anatomy. This difference raises the possibility of different effectiveness. We performed a variety of controlled experiments on phantom and clinical data to demonstrate that it performs as well or better than our predicate device and is comparable to experts. Based on this testing, we conclude that F3 is as safe and effective as our predicate device.

Registration Target – The F3 uses anatomy present and the Cydar EV uses vertebral anatomy. F3’s Mutual information will use vertebral anatomy to guide registration but will also utilize other structures present in both the CT and the fluoroscopic image to enhance the accuracy and robustness of the registration. This difference raises the possibility of different effectiveness. We performed a variety of controlled experiments on phantom and clinical data to demonstrate that it performs as well or better than our predicate device and is comparable to experts. Based on this testing, we conclude F3 is as safe and effective as our predicate device.

Ability to store roadmaps - F3 is a visualization aid, not intended to support planning roadmaps. This issue raises no new issues of safety and effectiveness.

Nonclinical Performance Testing Standards used:

● IEC 62304:2006 Medical Device software – Software life cycle processes

● IEC 62366: Edition 1.0 2015-02 Medical devices – Part 1: Application of usability engineering to medical devices

● ISO 14971: Third Edition 2019 medical device – Application of risk management to medical devices Summary of Nonclinical Performance Testing We performed our test of clinical acceptance based on clinical standards. For our evaluation with phantom data we utilized an thoracic phantom designed to provide realistic arms abducted, thoracic imaging for CT and plain X-ray. For our evaluation with clinical data, 20 cases were utilized that were collected retrospectively over a 2 year period. Qualifying cases were those in which a fluoroscopic procedure had been done with the appropriate F3 setup criteria (i.e. AP fluoroscopic video of the thorax and a thoracic CT in which the field of view of axial slices did not crop any part of the body). The resulting selected cases ranged from 29 to 71 years old, with a mean age of 56.3 years and a standard deviation of 11.9. 8 cases were female. We demonstrated for both rigid 6 parameter registration and for our dynamic panning that (1) our solution produces similar target registration error (TRE) to our predicate device on a thoracic phantom, (2) our solution produces clinically acceptable accuracy as defined by our predicate device as 3mm on clinical thoracic images that have been captured from an F3 configured setup, and (3) that our solution creates results that are preferred qualitatively by a group of board certified radiologists. Clinical Studies No clinical studies were done.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026